Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis
- 1 January 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 12 (2) , 97-99
- https://doi.org/10.1007/s10156-006-0431-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993–2002: continuous increasing of ciprofloxacin-resistant isolatesInternational Journal of Antimicrobial Agents, 2004
- Remarkable Increase in Central Japan in 2001-2002 of Neisseria gonorrhoeae Isolates with Decreased Susceptibility to Penicillin, Tetracycline, Oral Cephalosporins, and FluoroquinolonesAntimicrobial Agents and Chemotherapy, 2004
- Current concepts in the management of gonorrhoeaExpert Opinion on Pharmacotherapy, 2002
- Outbreak of Cefozopran (Penicillin, Oral Cephems, and Aztreonam)-Resistant Neisseria gonorrhoeae in JapanAntimicrobial Agents and Chemotherapy, 2001
- Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce β-lactamaseJournal of Infection and Chemotherapy, 2001
- Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeaeAntimicrobial Agents and Chemotherapy, 1983
- In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporinAntimicrobial Agents and Chemotherapy, 1981